跳至主要内容
临床试验/EUCTR2005-003885-40-IT
EUCTR2005-003885-40-IT进行中(未招募)不适用

ACE-inhibitors and Angiotensin two receptor antagonists in IgA nephropathy with mild proteinuria

AZIENDA OSPEDALIERA PROVINCIALE DI LECCO0 个研究点开始时间: 2007年1月15日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
AZIENDA OSPEDALIERA PROVINCIALE DI LECCO

相似试验

已完成
不适用
Angiotensin Converting Enzyme (ACE) inhibition for the preservation of renal function and patient survival in kidney transplantatioChronic kidney disease in renal transplant patientsUrological and Genital DiseasesChronic kidney disease
ISRCTN78129473Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute528
招募中
不适用
Management of angiotensin inhibitors during the perioperative period.on-cardiac major surgery
NL-OMON25483niversity Medical Center Utrecht, The Netherlands3,200
进行中(未招募)
1 期
Angiotensin Converting Enzyme Inhibitor (ACE) Induced AngioedemaBERINERTRandomized, double-blind, two arms, multicenter, Phase III study of Berinert for treatment of ACE induced AngioedemaAngiotensin – Converting – Enzyme – Inhibitors (ACEi) are used in the treatment of several types of cardiovascular and renal diseases. A known side effect of ACEi are angioedema of the head and neck region. These can lead to severe dyspnoea and the need for intubation and are thought to be bradykinin mediated. Up until now there is no study-evaluated conservative therapeutic concept for the treatment of these patients.MedDRA version: 18.1Level: HLTClassification code 10002425Term: AngioedemasSystem Organ Class: 100000004870
EUCTR2012-001670-28-DEMedizinische Fakultät der Technischen Universität München52
已完成
不适用
Angiotensin receptor blocker/Calcium antagonist combination therapy on diurnal blood pressure variatioHypertension
JPRN-UMIN000013050Jichi Medical University School of Medicine200
已完成
不适用
The effects of angiotensin II receptor blockers (ARBs) on oxidative stress and atherosclerosis in patients with hypertension.Patients with hypertension
JPRN-UMIN000001300Second Department of Internal Medicine, Nagasaki University School of Medicine120